Heart Test Laboratories (NASDAQ:HSCS) Trading Up 8.1% – Still a Buy?

Heart Test Laboratories, Inc. (NASDAQ:HSCS)’s stock price was up 8.1% during mid-day trading on Monday . The stock traded as high as $4.07 and last traded at $3.86. Approximately 51,920 shares traded hands during trading, a decline of 57% from the average daily volume of 122,097 shares. The stock had previously closed at $3.57.

Analysts Set New Price Targets

Separately, Ascendiant Capital Markets dropped their price objective on Heart Test Laboratories from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, March 18th.

Heart Test Laboratories Stock Up 8.1%

The firm’s 50-day moving average price is $3.54 and its two-hundred day moving average price is $3.47. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.52 and a current ratio of 1.72. The firm has a market cap of $4.17 million, a PE ratio of -0.49 and a beta of 2.56.

Institutional Investors Weigh In On Heart Test Laboratories

A hedge fund recently bought a new stake in Heart Test Laboratories stock. Astoria Strategic Wealth Inc. acquired a new position in shares of Heart Test Laboratories, Inc. (NASDAQ:HSCS) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 18,927 shares of the company’s stock, valued at approximately $53,000. Astoria Strategic Wealth Inc. owned about 1.75% of Heart Test Laboratories as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 17.24% of the company’s stock.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.